人福医药(600079.SH)：咪达唑仑注射液获德国上市许可批准

Core Viewpoint - The company, Renfu Pharmaceutical, has received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) for the marketing authorization of midazolam injection, indicating a significant advancement in its product portfolio and potential market expansion in Germany [1]. Group 1 - The approved indications for midazolam injection include: 1) sedation before, during, and after diagnostic or therapeutic procedures, with or without local anesthesia; 2) preoperative medication for adult anesthesia induction, anesthesia induction, and use in combination with other anesthetics as a sedative; preoperative medication for pediatric anesthesia induction; 3) sedation in the Intensive Care Unit (ICU) [1].